CVRX CVRx, Inc.
Nasdaq · SEC CIK 1235912 · EDGAR
- Bought, last 12 months
- $376.9K 3 purchases by 2 insiders
- Sold, last 12 months
- $129.9K 6 sales by 6 insiders
- Filings on record
- 145 since 2021-07-01, latest 2026-08-13 20:18
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Jain Mudit K. | Dir | $300.4K | — |
| Binkowski Brent | COO | $76.4K | $3,338 |
| Hykes Kevin | Pres, CEO, Dir | — | $61.3K |
| John Robert Allen | Chief Revenue Off | — | $31.3K |
| OASHEIM JARED | CFO | — | $13.8K |
| VERRASTRO PAUL | CHIEF MKTG, STRAT Off | — | $10.1K |
| Adamson Philip B. | Chief Medical Off | — | $9,970 |
| SHADAN MARTHA | Dir | — | — |
| Hill, Mitch C. | Dir | — | — |
| Ballinger Kevin J. | Dir | — | — |
Transactions 97
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 20:18 | 2026-08-13 | CVRX | Binkowski Brent | COO | P - Purchase | $2.91 | +26.2K | 56.5K | +87% | +$76.4K | |
| T | 2026-08-13 16:26 | 2026-08-12 | CVRX | Binkowski Brent | COO | S - Sale | $2.55 | -1,309 | 30.3K | -4% | -$3,338 |
| D | 2026-06-03 18:06 | 2026-06-01 | CVRX | Nielsen Kirk G. | Dir | A - Grant | $0.00 | +8,720 | 8,720 | New | $0 |
| D | 2026-06-03 18:06 | 2026-06-01 | CVRX | Jain Mudit K. | Dir | A - Grant | $0.00 | +8,720 | 14.4K | +154% | $0 |
| D | 2026-06-03 18:05 | 2026-06-01 | CVRX | SLATTERY JOSEPH P | Dir | A - Grant | $0.00 | +8,720 | 39.4K | +28% | $0 |
| D | 2026-06-03 18:05 | 2026-06-01 | CVRX | Hill, Mitch C. | Dir | A - Grant | $0.00 | +8,720 | 8,720 | New | $0 |
| D | 2026-06-03 18:05 | 2026-06-01 | CVRX | Ballinger Kevin J. | Dir | A - Grant | $0.00 | +8,720 | 8,720 | New | $0 |
| D | 2026-06-03 18:04 | 2026-06-01 | CVRX | SHADAN MARTHA | Dir | A - Grant | $0.00 | +8,720 | 8,720 | New | $0 |
| D | 2026-06-03 18:03 | 2026-06-01 | CVRX | DALE MICHAEL D | Dir | A - Grant | $0.00 | +29.0K | 29.0K | New | $0 |
| D | 2026-03-16 | 2026-03-02 | CVRX | Adamson Philip B. | Chief Medical Off | S - Sale | $7.90 | -1,262 | 61.6K | -2% | -$9,970 |
| D | 2026-03-16 | 2026-02-27 | CVRX | Adamson Philip B. | Chief Medical Off | A - Grant | $0.00 | +41.0K | 62.8K | +188% | $0 |
| D | 2026-03-04 | 2026-03-02 | CVRX | Morrison Gregory | CHRO | A - Grant | $0.00 | +34.0K | 34.0K | New | $0 |
| D | 2026-03-03 | 2026-02-27 | CVRX | VERRASTRO PAUL | CHIEF MKTG, STRAT Off | A - Grant | $0.00 | +45.0K | 61.8K | +267% | $0 |
| D | 2026-03-03 | 2026-03-02 | CVRX | VERRASTRO PAUL | CHIEF MKTG, STRAT Off | S - Sale | $7.90 | -1,284 | 60.6K | -2% | -$10.1K |
| D | 2026-03-03 | 2026-03-02 | CVRX | John Robert Allen | Chief Revenue Off | S - Sale | $7.90 | -3,964 | 86.0K | -4% | -$31.3K |
| D | 2026-03-03 | 2026-02-27 | CVRX | John Robert Allen | Chief Revenue Off | A - Grant | $0.00 | +35.0K | 90.0K | +64% | $0 |
| D | 2026-03-03 | 2026-02-27 | CVRX | OASHEIM JARED | CFO | A - Grant | $0.00 | +61.0K | 98.4K | +163% | $0 |
| D | 2026-03-03 | 2026-03-02 | CVRX | OASHEIM JARED | CFO | S - Sale | $7.90 | -1,744 | 96.7K | -2% | -$13.8K |
| D | 2026-03-03 | 2026-02-27 | CVRX | Hykes Kevin | Pres, CEO, Dir | A - Grant | $0.00 | +159.0K | 292.0K | +120% | $0 |
| D | 2026-03-03 | 2026-03-02 | CVRX | Hykes Kevin | Pres, CEO, Dir | S - Sale | $7.90 | -7,763 | 284.2K | -3% | -$61.3K |
| D | 2026-03-03 | 2026-02-27 | CVRX | Binkowski Brent | COO | A - Grant | $0.00 | +15.0K | 31.6K | +90% | $0 |
| I | 2026-02-23 | 2026-02-20 | CVRX | Jain Mudit K. | Dir | P - Purchase | $6.36 | +46.8K | 980.2K | +5% | +$297.6K |
| 2026-02-18 | 2026-02-18 | CVRX | Jain Mudit K. | Dir | P - Purchase | $4.64 | +600 | 5,650 | +12% | +$2,784 | |
| D | 2025-08-13 | 2025-08-11 | CVRX | Binkowski Brent | COO | A - Grant | $0.00 | +16.6K | 16.6K | New | $0 |
| I | 2025-05-19 | 2025-05-15 | CVRX | Nielsen Kirk G. | Dir | P - Purchase | $5.45 | +11.0K | 1.91M | +0.6% | +$59.8K |
| MI | 2025-05-14 | 2025-05-12+ | CVRX | Nielsen Kirk G. | Dir | P - Purchase | $5.20 | +187.8K | 1.74M | +12% | +$977.3K |
| M | 2025-05-13 | 2025-05-12+ | CVRX | Jain Mudit K. | Dir | P - Purchase | $4.71 | +1,650 | 4,900 | +51% | +$7,779 |
| 2025-05-12 | 2025-05-12 | CVRX | Hykes Kevin | Pres, CEO, Dir | P - Purchase | $4.84 | +5,000 | 133.0K | +4% | +$24.2K | |
| D | 2025-03-04 | 2025-02-28 | CVRX | VERRASTRO PAUL | CHIEF MKTG, STRAT Off | A - Grant | $0.00 | +16.0K | 16.8K | +1,916% | $0 |
| D | 2025-03-04 | 2025-02-28 | CVRX | Adamson Philip B. | Chief Medical Off | A - Grant | $0.00 | +20.0K | 20.0K | New | $0 |
| D | 2025-03-04 | 2025-02-28 | CVRX | Hykes Kevin | Pres, CEO, Dir | A - Grant | $0.00 | +98.0K | 128.0K | +327% | $0 |
| D | 2025-03-04 | 2025-02-28 | CVRX | John Robert Allen | Chief Revenue Off | A - Grant | $0.00 | +55.0K | 55.0K | New | $0 |
| D | 2025-03-04 | 2025-02-28 | CVRX | OASHEIM JARED | CFO | A - Grant | $0.00 | +22.0K | 37.4K | +142% | $0 |
| D | 2024-11-21 | 2024-11-19 | CVRX | VERRASTRO PAUL | CHIEF MKTG, STRAT Off | S - Sale+OE | $13.58 | -1,430 | 1,875 | -43% | -$19.4K |
| D | 2024-11-21 | 2024-11-19 | CVRX | VERRASTRO PAUL | CHIEF MKTG, STRAT Off | M - OptEx | $5.14 | +2,500 | 3,305 | +311% | +$12.8K |
| D | 2024-11-21 | 2024-11-21 | CVRX | VERRASTRO PAUL | CHIEF MKTG, STRAT Off | G - Gift | $0.00 | -1,040 | 835 | -55% | $0 |
| 2024-08-15 | 2024-08-15 | CVRX | SLATTERY JOSEPH P | Dir | P - Purchase | $8.10 | +3,000 | 30.6K | +11% | +$24.3K | |
| 2024-08-08 | 2024-08-08 | CVRX | SLATTERY JOSEPH P | Dir | P - Purchase | $8.24 | +3,000 | 27.6K | +12% | +$24.7K | |
| 2024-08-06 | 2024-08-06 | CVRX | SLATTERY JOSEPH P | Dir | P - Purchase | $9.09 | +2,500 | 24.6K | +11% | +$22.7K | |
| 2024-08-05 | 2024-08-05 | CVRX | Hykes Kevin | Pres, CEO, Dir | P - Purchase | $8.36 | +30.0K | 30.0K | New | +$250.8K | |
| DM | 2024-03-27 | 2024-03-25 | CVRX | Palmer Craig E. | SVP, U.S. SALES | M - OptEx | $0.24 | +934 | 674 | New | +$224.16 |
| 2024-02-27 | 2024-02-23 | CVRX | VERRASTRO PAUL | CHIEF MKTG, STRAT Off | G - Gift | $0.00 | -1,650 | 805 | -67% | $0 | |
| D | 2024-02-22 | 2024-02-20 | CVRX | VERRASTRO PAUL | CHIEF MKTG, STRAT Off | S - Sale+OE | $21.91 | -2,545 | 2,455 | -51% | -$55.8K |
| D | 2024-02-22 | 2024-02-20 | CVRX | VERRASTRO PAUL | CHIEF MKTG, STRAT Off | M - OptEx | $5.14 | +5,000 | 5,000 | New | +$25.7K |
| DM | 2024-01-31 | 2024-01-29 | CVRX | Yared Nadim | CEO, Dir | M - OptEx | $0.24 | +6,000 | 24.3K | +33% | +$1,440 |
| DM | 2024-01-02 | 2023-12-28 | CVRX | SLATTERY JOSEPH P | Dir | M - OptEx | $0.5079 | +1,950 | 22.0K | +10% | +$990.42 |
| D | 2023-12-18 | 2023-12-14 | CVRX | Behbahani Ali | Dir | M - OptEx | $0.24 | +316 | 316 | New | +$75.84 |
| D | 2023-10-18 | 2023-10-16 | CVRX | Galle Liz | VP OF Gbl CLINICAL RESEARCH | M - OptEx | $0.24 | +778 | 778 | New | +$186.72 |
| DM | 2023-09-20 | 2023-09-18 | CVRX | OASHEIM JARED | CFO | M - OptEx | $3.63 | +5,862 | 10.1K | +138% | +$21.3K |
| 2023-09-18 | 2023-09-15 | CVRX | Johnson & Johnson Innovation - JJDC, Inc. | 10% | J - Other | — | -3.50M | 0 | -100% | — | |
| 2023-08-07 | 2023-08-03 | CVRX | VERRASTRO PAUL | CHIEF MKTG, STRAT Off | S - Sale | $18.55 | -628 | 0 | -100% | -$11.6K | |
| D | 2023-08-02 | 2023-08-02 | CVRX | VERRASTRO PAUL | CHIEF MKTG, STRAT Off | G - Gift | $0.00 | -2,000 | 628 | -76% | $0 |
| D | 2023-08-02 | 2023-07-31 | CVRX | VERRASTRO PAUL | CHIEF MKTG, STRAT Off | S - Sale+OE | $17.49 | -1,122 | 2,628 | -30% | -$19.6K |
| D | 2023-08-02 | 2023-07-31 | CVRX | VERRASTRO PAUL | CHIEF MKTG, STRAT Off | M - OptEx | $5.14 | +3,750 | 3,750 | New | +$19.3K |
| D | 2023-05-18 | 2023-05-16 | CVRX | Palmer Craig E. | SVP, U.S. SALES | M - OptEx | $0.24 | +295 | 295 | New | +$70.80 |
| 2023-01-13 | 2023-01-11 | CVRX | Yared Nadim | CEO, Dir | G - Gift | $0.00 | -7,080 | 20.3K | -26% | $0 | |
| D | 2022-11-30 | 2022-11-28 | CVRX | VERRASTRO PAUL | CHIEF MKTG, STRAT Off | M - OptEx | $5.14 | +9,000 | 9,000 | New | +$46.3K |
| DM | 2022-11-30 | 2022-11-28 | CVRX | VERRASTRO PAUL | CHIEF MKTG, STRAT Off | S - Sale+OE | $11.94 | -4,600 | 4,400 | -51% | -$54.9K |
| D | 2022-11-30 | 2022-11-30 | CVRX | VERRASTRO PAUL | CHIEF MKTG, STRAT Off | G - Gift | $0.00 | -4,400 | 0 | -100% | $0 |
| DM | 2022-06-06 | 2022-06-02 | CVRX | OASHEIM JARED | CFO | M - OptEx | $0.24 | +9,585 | 6,952 | New | +$2,300 |
| I | 2022-05-26 | 2022-05-24 | CVRX | Nielsen Kirk G. | Dir | P - Purchase | $5.05 | +8,070 | 1.71M | +0.5% | +$40.8K |
| MI | 2022-05-23 | 2022-05-19+ | CVRX | Nielsen Kirk G. | Dir | P - Purchase | $5.04 | +28.8K | 1.69M | +2% | +$145.1K |
| MI | 2022-05-05 | 2022-05-03+ | CVRX | Nielsen Kirk G. | Dir | P - Purchase | $6.00 | +62.3K | 1.67M | +4% | +$373.6K |
| MI | 2022-05-02 | 2022-04-28+ | CVRX | Nielsen Kirk G. | Dir | P - Purchase | $5.97 | +42.1K | 1.57M | +3% | +$251.3K |
| D | 2022-04-27 | 2022-04-25 | CVRX | Yared Nadim | CEO, Dir | M - OptEx | $0.24 | +6,059 | 27.3K | +28% | +$1,454 |
| DM | 2022-04-26 | 2022-04-22 | CVRX | BRINTNALL JOHN | Chief STRATEGY Off. AND SEC | M - OptEx | $0.24 | +11.5K | 14.6K | +361% | +$2,748 |
| 2022-03-02 | 2022-02-28 | CVRX | Jain Mudit K. | Dir | P - Purchase | $9.03 | +600 | 3,400 | +21% | +$5,418 | |
| I | 2022-02-28 | 2022-02-24 | CVRX | Nielsen Kirk G. | Dir | P - Purchase | $8.24 | +3,400 | 1.57M | +0.2% | +$28.0K |
| MI | 2022-02-23 | 2022-02-18+ | CVRX | Nielsen Kirk G. | Dir | P - Purchase | $7.97 | +104.9K | 1.53M | +7% | +$835.9K |
| DM | 2022-02-10 | 2022-02-08 | CVRX | BRUHN-DING DEAN | VP of Reg. Affairs, QA | M - OptEx | $0.24 | +35.0K | 32.8K | New | +$8,400 |
| DM | 2022-02-07 | 2022-02-03 | CVRX | Yared Nadim | CEO, Dir | M - OptEx | $0.24 | +18.7K | 20.0K | +1,416% | +$4,486 |
| D | 2022-01-20 | 2022-01-19 | CVRX | Yared Nadim | CEO, Dir | G - Gift | $0.00 | -10.5K | 2,586 | -80% | $0 |
| DM | 2022-01-18 | 2022-01-13 | CVRX | SLATTERY JOSEPH P | Dir | M - OptEx | $0.2877 | +11.6K | 18.9K | +161% | +$3,348 |
| D | 2022-01-03 | 2021-12-30 | CVRX | BRINTNALL JOHN | Chief Strategy Off, Sec | M - OptEx | $0.24 | +2,550 | 10.4K | +32% | +$612 |
| D | 2021-12-30 | 2021-12-28 | CVRX | Yared Nadim | CEO, Dir | M - OptEx | $0.24 | +2,080 | 13.1K | +19% | +$499.20 |
| D | 2021-12-02 | 2021-11-30 | CVRX | SLATTERY JOSEPH P | Dir | M - OptEx | $0.24 | +3,000 | 8,555 | +54% | +$720 |
| D | 2021-11-29 | 2021-11-24 | CVRX | BRUHN-DING DEAN | VP of Reg. Affairs, QA | M - OptEx | $0.24 | +14.0K | 19.6K | +248% | +$3,360 |
| D | 2021-11-24 | 2021-11-22 | CVRX | Yared Nadim | CEO, Dir | M - OptEx | $0.24 | +11.0K | 11.0K | New | +$2,641 |
| M | 2021-11-19 | 2021-11-18+ | CVRX | Jain Mudit K. | Dir | P - Purchase | $14.39 | +1,175 | 2,500 | +89% | +$16.9K |
| 2021-08-16 | 2021-08-12 | CVRX | Jain Mudit K. | Dir | P - Purchase | $19.72 | +625 | 1,625 | +62% | +$12.3K | |
| DM | 2021-07-07 | 2021-07-02 | CVRX | NEW ENTERPRISE ASSOCIATES 10 L P | 10% | C - Cnv Deriv | — | +1.80M | 115.4K | New | — |
| D | 2021-07-07 | 2021-07-02 | CVRX | NEW ENTERPRISE ASSOCIATES 10 L P | 10% | P - Purchase | $18.00 | +225.5K | 2.03M | +13% | +$4.06M |
| DMI | 2021-07-07 | 2021-07-02 | CVRX | NEA PARTNERS 10 L P | 10% | C - Cnv Deriv | — | +1.95M | 1.80M | New | — |
| DMI | 2021-07-07 | 2021-07-02 | CVRX | NEA PARTNERS 10 L P | 10% | P - Purchase | $18.00 | +250.2K | 2.03M | +14% | +$4.50M |
| DMI | 2021-07-06 | 2021-07-02 | CVRX | GLAXOSMITHKLINE PLC | 10% | C - Cnv Deriv | — | +700.8K | 732.6K | +2,203% | — |
| DI | 2021-07-06 | 2021-07-02 | CVRX | GLAXOSMITHKLINE PLC | 10% | P - Purchase | $18.00 | +275.0K | 1.01M | +38% | +$4.95M |
| DI | 2021-07-02 | 2021-07-02 | CVRX | Nielsen Kirk G. | Dir | C - Cnv Deriv | — | +1.46M | 1.46M | New | — |
| DI | 2021-07-02 | 2021-07-02 | CVRX | Pardo Geoffrey B | Dir | C - Cnv Deriv | — | +1.55M | 1.55M | New | — |
| DI | 2021-07-02 | 2021-07-02 | CVRX | Pardo Geoffrey B | Dir | P - Purchase | $18.00 | +275.0K | 1.83M | +18% | +$4.95M |
| 2021-07-02 | 2021-07-02 | CVRX | SLATTERY JOSEPH P | Dir | A - Grant | $18.00 | +5,555 | 5,555 | New | +$100.0K | |
| DM | 2021-07-02 | 2021-07-02 | CVRX | BRINTNALL JOHN | Chief Strategy Off, Sec | C - Cnv Deriv | — | +7,900 | 7,900 | New | — |
| D | 2021-07-02 | 2021-07-01 | CVRX | Jain Mudit K. | Dir | P - Purchase | $25.10 | +1,000 | 1,000 | New | +$25.1K |
| DI | 2021-07-02 | 2021-07-02 | CVRX | Jain Mudit K. | Dir | C - Cnv Deriv | — | +711.2K | 711.2K | New | — |
| DI | 2021-07-02 | 2021-07-02 | CVRX | Jain Mudit K. | Dir | P - Purchase | $18.00 | +222.2K | 933.4K | +31% | +$4.00M |
| 2021-07-02 | 2021-07-02 | CVRX | NEHRA JOHN M | Dir | P - Purchase | $18.00 | +27.8K | 28.3K | +5,680% | +$500.0K | |
| MI | 2021-07-02 | 2021-06-30+ | CVRX | NEHRA JOHN M | Dir | P - Purchase | $26.61 | +100 | 50 | New | +$2,662 |
| DI | 2021-07-02 | 2021-07-02 | CVRX | Johnson & Johnson Innovation - JJDC, Inc. | 10% | C - Cnv Deriv | — | +3.50M | 3.50M | New | — |
Purchase Sale Sale after option exercise All abbreviations